Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Finasteride increases P-glycoprotein activity in the liver and kidney.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Improved CRBN ligands make protein degraders more effective and drug-like.

Phospholipase C-δ1 is crucial for normal hair development.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Panax notoginseng saponins help hair growth in mice.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Targeting LPA could help treat skin disorders.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Both enzyme forms can sulfate minoxidil.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Increasing TSPO in the brain reduces anxiety and depression.